This is notable as Wnt5a is an identified ligand for ROR1 [13], an evolutionarily conserved and developmentally-restricted type-I surface protein, which is expressed by the leukemia cells of most patients with CLL [13–15]. This evidence concerns the gene WNT5A and B-cell chronic lymphocytic leukemia.